MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MTVA is expected to report earnings to fall 6.75% to -73 cents per share on November 16
Q3'26
Est.
$-0.74
Q1'26
Missed
by $0.45
Q4'25
Missed
by $0.52
Q3'25
Beat
by $0.18
Q2'25
Beat
by $0.06
The last earnings report on May 14 showed earnings per share of -79 cents, missing the estimate of -34 cents. With 29.66K shares outstanding, the current market capitalization sits at 9.62M.